Your session is about to expire
← Back to Search
Low-Carb High-Fat breakfast for Eating Habits
N/A
Waitlist Available
Research Sponsored by University of British Columbia
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up first 14 days and last 14 days of the study
Awards & highlights
No Placebo-Only Group
Summary
This trial tests if eating a low-carb, high-fat breakfast can help people with Type 2 Diabetes manage their health better. They will follow this breakfast routine for several months. The goal is to see if this simple change can improve their overall health by keeping their blood sugar more stable.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ first 14 days and last 14 days of the study
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~first 14 days and last 14 days of the study
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change from Baseline Hemoglobin A1c at 12 weeks
Secondary study objectives
Change from Baseline Blood Lipids at 12 weeks
Change from Baseline Body Mass Index at 12 weeks
Change from Baseline Body weight at 12 weeks
+6 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Low-Carb High-Fat BreakfastExperimental Treatment1 Intervention
Participants will follow a daily low carbohydrate high fat breakfast intervention for 3 months.
Group II: Low fat "Standard Care" Control BreakfastActive Control1 Intervention
Participants will follow a daily low fat "standard care" control breakfast intervention for 3 months.
Find a Location
Who is running the clinical trial?
University of British ColumbiaLead Sponsor
1,465 Previous Clinical Trials
2,485,404 Total Patients Enrolled
University of WollongongOTHER
8 Previous Clinical Trials
13,572 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger